Seelos Therapeutics, Inc. Tangible Net Worth Ratio
Seelos Therapeutics, Inc. tangible net worth ratio. Seelos Therapeutics, Inc. (SEELQ) has a Tangible Net Worth Ratio of 100.0% as of December 2021. This metric is calculated by deducting intangible assets ($0.00) from net assets ($57.32 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See how leveraged is Seelos Therapeutics, Inc.'s balance sheet to measure how much of total assets are equity-financed.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Tangible Net Worth Ratio of Seelos Therapeutics, Inc. (2020–2021)
Tangible net worth ratio of Seelos Therapeutics, Inc. from 2020 to 2021. This chart shows how Seelos Therapeutics, Inc.'s Tangible Net Worth Ratio has changed across 2 annual periods from 2020 to 2021. As of December 2021, the ratio stands at 100.0%, reflecting net assets of $57.32 Million with intangible assets of $0.00 USD. See Seelos Therapeutics, Inc. (SEELQ) working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Seelos Therapeutics, Inc. Tangible Net Worth Ratio by Year (2020–2021)
Seelos Therapeutics, Inc. tangible net worth ratio by year from 2020 to 2021. The table below presents the year-by-year Tangible Net Worth Ratio for Seelos Therapeutics, Inc. from 2020 to 2021, covering 2 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For live market cap and overall valuation, see how much is Seelos Therapeutics, Inc. worth.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2021 | 100.0% | $57.32 Million | $0.00 | $83.50 Million | ▲ +0.0 pp |
| 2020 | 100.0% | $2.57 Million | $0.00 | $17.49 Million | — |